Reposted by Sia At The Game
From @reuters.com: Biopharma company Halozyme said on Wednesday that a Dutch patent court ruled in its favor against Merck, ordering the drugmaker to halt the manufacture and sale of injectable Keytruda in eight European markets. buff.ly/OjdXyaL
buff.ly
https://www.reuters.com/legal/litigation/halozyme-wins-court-order-block-mercks-injected-keytruda-select-european-markets-2026-10-07/